Historical development of the understanding of coeliac disease

Biljana  Stojanović; Sveta  Janković; Nela  Djonović; Vladimir Radlović; Stevan Jovanović; Biljana  Vuletić

doi:10.2298/VSP180727065S

Biljana Stojanović High Health School of Professional Studies, Belgrade, Serbia
Sveta Janković University of Kragujevac, Faculty of Medical Sciences, Kragujevac, Serbia
Nela Djonović Clinical Center of Kragujevac, Pediatric Clinic Kragujevac, Serbia
Vladimir Radlović University of Belgrade, Faculty of Medicine, Belgrade Serbia
Stevan Jovanović High Health School of Professional Studies, Belgrade, Serbia
Biljana Vuletić University of Kragujevac, Faculty of Medical Sciences, Kragujevac, Serbia

DOI: https://doi.org/10.2298/VSP180727065S

Keywords: biopsy, celiac disease, diagnosis, history of medicine, therapeutics

References

REFERENCES

Abadie V, Sollid LM, Barreiro LB, Jabri B. Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Ann Rev Immunol 2011; 29: 493-525. (English)

Mustalahti K, Catassi C, Reunanen A, Fabiani E, Heier M, McMillan S, et al. The prevalence of celiac disease in Europe: Results of a centralized, international mass screening project. Ann Med 2010; 42: 587-95. (English)

Ludvigsson ЈF, Card TR, Kaukinen K, Bai J, Zingone F, Sanders DS, et al. Screening for celiac disease in the general population and in high-risk groups. United European Gastroenterol J 2015; 3(2): 106-20. (English)

Radlović N. Celiac disease. Srp Arh Celok Lek 2013; 141(1-2): 122–6. (English)

Troncone R, Auricchio S. Celiac disease. In: Wyllie R, Hyams JS, editors. Pediatric Gastrointestinal and Liver Disease. Philadelphia: Saunders Elsevier Inc; 2006. p. 517-27. (English)

Mäki M. Celiac disease. In: Kleinman RE, Sanderson IR, Goulet O, Sherman PM, Mieli-Vergani G, Shneider BL, editors. Walker’s Pediatric Gastrointestinal Disease. Hamilton: BC Decker Inc; 2008. p. 319-27. (English)

Working Group of European Society of Paediatric Gastroenterology and Nutrition. Revised criteria for diagnosis of coeliac disease. Report. Arch Dis Child 1990; 65: 909-11. (English)

Marsh M. Mucosal pathology in gluten sensitivity. In: Marsh M, editor. Coeliac disease. Oxford: Blackwell Sci Publ; 1992. p. 136-91. (English)

Arranz E, Bode J, Kingstone K, Ferguson A. Intestinal antibody pattern of coeliac disease: association with γ/δ T cell receptor expression by intra-epitelial lymphocytes and other indices of potential coeliac disease. Gut 1994; 35: 476-82. (English)

Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med 2002; 346(3): 180-8. (English)

Catassi C, Fabiani E, Iacono G, D'Agate C, Francavilla R, Biagi F, et al. A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. American Journal of Clinical Nutrition. 2007; 85(1): 160–6. (English)

Tjon May-Ling J, Van Bergen J, Koning F. Celiac disease: how complicated can it get? Immunogenetics. 2010; 62: 641-51. (English)

Freeman HJ. The Neolithic Revolution and Subsequent Emergence of the Celiac Affection. International Journal of Celiac Disease. 2013; 1(1): 19-22. (English)

Adams F, translator. „On The Cœliac Affection“. The extant works of Aretaeus, The Cappadocian. London: Sydenham Society. 1856, 350-1. Dostupno na URL: https://books.google.rs/books?id=v4gIAAAAIAAJ&pg=PA350&redir_esc=y#v=onepage&q&f=false)

Gee, S. J., St. Bartholomew's Hospital Reports, 1888, 24, 17. Dostupno na URL: https://web.archive.org/web/20070926231536/http://web2.bium.univ-paris5.fr/livanc/?cote=epo0466&p=1&do=page

Abel EK. The Rise and Fall of Celiac Disease in the United States. J Hist Med Allied Sci 2010; 65(1): 81-105. (English)

Herter CA. On intestinal infantilism from chronic intestinal infection. New York: Macmillan; 1908. (English)

Haas SV, Haas MP. The treatment of celiac disease with the specific carbohydrate diet; report on 191 additional cases. Am J Gastroenterol 1955; 23(4): 344-60. (English)

Brown A. Some Etiological Factors in the Coeliac Syndrome. Arch Dis Child 1949; 24(118): 99–106. (English)

Parsons LG. Coeliac disease. Am J Dis Child 1932; 43: 1293-346. (English)

Dicke WK. Coeliac disease: Investigation of the harmfull effects of certan types of cereal on patients with coeliac disease (Coeliakie: een onderzoek naar de nadelige invloed van sommige graansoorten op de lijder aan coeliakie) [MD Thesis]. Netherlands: University of Utrecht; 1950 (Dutch).

Anderson C, French J, Sammons H, Frazer A, Gerrard J, Smellie J. Coeliac disease; gastrointestinal studies and the effect of dietary wheat flour. Lancet 1952; 1(17):836-42. (English)

Shiner, M. Jejunal-biopsy tube. Lancet 1956; 1:85. (English)

Royer M, Croxatto O, Biempica L, Balcazar Morrison AJ. Duodenal biopsy by aspiration under radioscopic control. Prensa Med Argent 1955; 42(33): 2515-9. (Spanish)

Shiner M. Small intestinal biopsies by the oral route; histopathologic changes in the malabsorption syndrome. J Mt Sinai Hosp N Y 1957; 24(3): 273-85. (English)

Weijers HA, Van de Kamer JH, Dicke WK. Coeliac disease. II. The presence in wheat of a factor having a deleterious effect in cases of coeliac disease. Advanced Pediatric. 1957; 9: 277-318. (English)

Crosby WH, Kugler HW. Intraluminal biopsy of the small intestine: the intestinal biopsy capsule. Dig Dis Sci 1957; 2: 236-39. (English)

Koprowski R. Overview of technical solutions and assessment of clinical usefulness of capsule endoscopy. Biomed Eng Online 2015; 14: 111. (English)

Ciaccio EJ, Lewis SK, Bhagat G, Green PH. Coeliac disease and the videocapsule: what have we learned till now. Ann Transl Med 2017; 5(9): 197. (English)

Paulley JW. Observation on the aetiology of idiopathic steatorrhoea; jejunal and lymph-node biopsies. Br Med J 1954; 2(4900): 1318-21. (English)

Sakula J, Shiner M. Coeliac disease with atrophy of the small-intestine mucosa. Lancet. 1957; 273(7001): 876-7. (English)

Macdonald WC, Dobbins WO, Rubin CE. Studies of the familial nature of celiac sprue using biopsy of the small intestine. N Engl J Med 1965; 272(9): 448-56. (English)

Meuwisse GW. Diagnostic criteria in coeliac disease. Acta Paediatr Scand 1970; 59: 461-3. (English)

Ferguson A, MacDonald TT, McClure JP, Holden RJ. Cell-mediated immunity to gliadin within the small-intestinal mucosa in coeliac disease. Lancet 1975; 1: 895-7. (English)

Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology 1992; 102: 330-54. (English)

Lundin KE, Scott H, Hansen T, Paulsen G, Hals-tensen TS, Fausa O et al. Gliadin-specific, HLA-DQ(a1*0501,b1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 1993; 178: 187-96. (English)

Lundin KA, Scott H, Fausa O, Thorsby E, Sollid LM. T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum Immunol 1994; 41: 285-91. (English)

Mäki M, Hällström O, Marttinen A. Reaction of human noncollagenous polypeptides with coeliac disease autoantibodies. Lancet 1991; 338: 724-5. (English)

Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO et al. Identifi cation of tissue transgluta-Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3: 797-801. (English)

van de Wal Y, Kooy Y, van Veelen P, Pena S, Mearin L, Papadopoulos G et al. Selective deamidation by tissue transglutaminase strongly en-hances gliadin-specific T cell reactivity. J Immunol 1998; 161: 1585-8. (English)

Molberg O, Mcadam SN, Körner R, Quarsten H, Kristiansen C, Madsen L et al. Tissue transglutaminase selectively modifies gliadin peptides that are recog nized by gut-derived T cells in celiac disease. Nat Med 1998; 4: 713-7. (English)

Osman AA, Gunnel T, Dietl A, Uhlig HH, Amin M, Fleckenstein B et al. B-cell epitopes of gliadin. Clin Exp Immunol 2000; 121: 248-54. (English)

Aleanzi M, Demonte AM, Esper C, Garcilazo S, Waggener M. Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides. Clin Chem 2001; 47: 2023-8. (English)

Arentz-Hansen H, Körner R, Molberg O, Quarsten H, Vader W, Kooy YM et al. The intestinal T cell re-The intestinal T cell re-sponse to alpha-gliadin in adult celiac disease is fo-cused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 2000; 191: 603-12. (English)

Kuja-Halkola R, Lebwohl B, Halfvarson J, Wijmenga C, Magnusson PK, Ludvigsson JF. Heritability of non-HLA genetics in coeliac disease: a population-based study in 107 000 twins. Gut 2016; 65: 1793-8. (English)

Dubois PC, Trynka G, Franke L, Hunt KA, Romanos J, Curtotti A, et al. Multiple common variants for celiac disease influencing immune gene expression. Nat Genet 2010; 42: 295-302. (English)

Volta U, Villanacci V. Celiac disease: diagnostic criteria in progress. Cell Mol Immunol 2011; 8(2): 96-102. (English)

Stene LC, Honeyman MC, Hoffenberg EJ, Haas JE, Sokol RJ, Emery L, et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol 2006; 101(10): 2333-40. (English)

Silano M, Agostoni C, Guandalini S. Effect of the timing of gluten introduction on the development of celiac disease. World J Gastroenterol 2010; 16(16): 1939-42. (English)

Sanz Y, De Pama G, Laparra M. Unraveling the ties between celiac disease and intestinal microbiota. Int Rev Immunol. 2011; 30(4): 207-18. (English)

du Pré MF, Sollid LM. T-cell and B-cell immunity in celiac disease. Best Pract Res Clin Gastroenterol 2015; 29: 413-23. (English)

Kim SM, Mayassi T, Jabri B. Innate immunity: actuating the gears of celiac disease pathogenesis. Best Pract Res Clin Gastroenterol 2015; 29: 425-35. (English)

Mazzarella G. Effector and suppressor T cells in celiac disease. World J Gastroenterol 2015; 21: 7349-56. (English)

Björck S, Lindehammer SR, Fex M, Agardh D. Serum cytokine pattern in young children with screening detected coeliac disease. Clin Exp Immunol 2015; 179(2): 230-5. (English)

Troncone R, Jabri B. Coeliac disease and gluten sensitivity. J Intern Med 2011; 269: 582-590. (English)

Matthias T, Neidhöfer S, Pfeiffer S, Prager K, Reuter S, Gershwin ME. Novel trends in celiac disease. Cell Mol Immunol 2011; 8: 121-125. (English)

Husby S, Koletzko S, Korponay-Szabo IR, Mearin ML, Phillips A, Shamir R, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012; 54:136-60. (English)

Gianfrani C, Siciliano RA, Facchiano AM, Camarca A, Mazzeo MF, Costantini S, et al. Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease. Gastroenterology 2007; 133: 780-9. (English)

Van den Broeck HC, Van Herpen TW, Schuit C, Salentijn EM, Dekking L, Bosch D, et al. Removing celiac disease-related gluten proteins from bread wheat while retaining technological properties: a study with Chinese Spring deletion lines. BMC Plant Biol 2009; 9:41-53. (English)

De Angelis M, Rizzello CG, Fasano A, Clemente MG, De Simone C, Silano M, et al. VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for celiac sprue. Biochim Biophys Acta 2006; 1762: 80-93. (English)

Gass J, Bethune MT, Siegel M, Spencer A, Khosla C. Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue. Gastroenterology 2007; 133: 472-80. (English)

Tye-Din JA, Anderson RP, Ffrench RA, Brown GJ, Hodsman P, Siegel M, et al. The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo. Clin Immunol 2010; 134: 289-95. (English)

Fuhrmann G, Leroux JC. In vivo fluorescence imaging of exogenous enzyme activity in the gastrointestinal tract. Proc Natl Acad Sci US A 2011; 108: 9032-7. (English)

Dhal PK, Polomoscanik SC, Avila LZ, Holmes-Farley SR, Miller RJ. Functional polymers as therapeutic agents: concept to market place. Adv Drug Deliv Rev 2009; 61: 1121-30. (English)

Leffler DA, Kelly CP, Green PHR, Fedorak RN, DiMariano A, Perrow W, Rasmussen H, et al. Larazotide Acetate for Persistent Symptoms of Celiac Disease Despite a Gluten-Free Diet: A Randomized Controlled Trial. Gastroenterology. 2015; 148(7): 1311-9. (English)

Paterson BM, Lammers KM, Arrieta MC, Fasano A, Meddings JB. The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study. Aliment Pharmacol Ther 2007; 26: 757-66. (English)

Huibregtse IL, Marietta EV, Rashtak S, Koning F, Rottiers P, David CS, et al. Induction of antigenspecific tolerance by oral administration of Lactococcus lactis delivered immunodominant DQ8-restricted gliadin peptide in sensitized nonobese diabetic Ab° Dq8 transgenic mice. J Immunol 2009; 183: 2390-6. (English)

Schuppan D, Junker Y, Barisani D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology 2009; 137: 1912-33. (English)

Pardin C, Roy I, Lubell WD, Keillor JW. Reversible and competitive cinnamoyl triazole inhibitors of tissue transglutaminase. Chem Biol Drug Des 2008; 72: 189-96. (English)

Ozaki S, Ebisui E, Hamada K, Goto J, Suzuki AZ, Terauchi A, et al. Potent transglutaminase inhibitors, aryl beta-aminoethyl ketones. Bioorg Med Chem Lett 2010; 20: 1141-4. (English)

Siegel M, Xia J, Khosla C. Structure-based design of alpha-amido aldehyde containing gluten peptide analogues as modulators of HLA-DQ2 and transglutaminase 2. Bioorg Med Chem 2007; 15: 6253-61. (English)

Sollid LM, Khosla C. Novel therapies for coeliac disease. J Intern Med 2011; 269: 604-13. (English)